0      0

Perspectives on the Adoption and Implementation


‐ Sep 11, 2020 5:08am


Credits: None available.

Perspectives on the Adoption and Implementation

Perspectives on the Adoption and Implementation of Continuous ManufacturingThis session will include 3 highly regarded experts in the CM for biological molecules. These experts will share perspectives and experiences on the development and potential adoption of CM for large molecules.

  • Integrated Approach to Semi-Continuous Drug Substance Manufacturing
    Mehdi Ghodbane, PhD, Downstream Process Development, Medicinal Science & Technology
    GlaxoSmithKline  
  • N-1 Perfusion from Development through GMP Implementation
    Gene Schaefer, Senior Director Large Molecule API Development
    Janssen
  • Sanofi’s MA Digitalized Facility, an Ecosystem of the Future
    Navin Tiwari, Director, Head of Digital Shop Floor & Automation
    Sanofi

Moderator(s):

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.